Most Recent Articles from Worldwide Biotech

• Qrxpharma/Liaoning Nuokang Medicines To Develop Venomics 

  QRxPharma(OTCQX:QRXPY), has announced a strategic alliance with Liaoning Nuokang Medicines Co. Ltd. (Nuokang), a Chinese biopharmaceutical company...

  11/01/09 · More from publication

• Methylgene To Resume Development Of Mgcd0103 

  MethylGene Inc. (TSX:MYG), Montreal, Quebec. has announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold...

  11/01/09 · More from publication

• Stemcells, Inc. To Advance Cell-Based Technologies 

  StemCells, Inc. (NASDAQ: STEM). Palo Alto, Calif., has announced organizational initiatives focused on growing its specialty SC ProvenR cell...

  11/01/09 · More from publication

• Malaysia Diagnostics/Devices Industry Outlook For 2009 

  Nitin Naik, vice president of the Healthcare, Asia Pacific said that the total Healthcare Expenditure grew at 13.70% CAGR from 2003 to 2008, which...

  10/01/09 · More from publication

• Bone Medical Gets Us Fda Guidance On Ind For Capsitonin 

  Bone Medical (ASX:BNE) has received a formal response from the US FDA to the IND application filed in June for Capsitonin(tm), its oral formulation...

  10/01/09 · More from publication

• Santhera/Biovail To Develop Jp-1730/Fipamezole In America 

  Santhera Pharmaceuticals (SIX: SANN), and Biovail Corporation (NYSE/TSX:BVF) has announced that the two specialty pharmaceutical companies have...

  10/01/09 · More from publication

View more »